Download - Leptospirosis UPH 2
![Page 1: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/1.jpg)
Leptospirosis
Sung Chul Hwang Dept. of Pulmonary and Critical Care MedicineAjou University School of Medicine
![Page 2: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/2.jpg)
LeptospiraLeptospira
Scanning electron micrograph of Leptospira interrogans strain RGA. Two spirochetes bound to a 0.2 µm filter.Strain RGAwas isolated in 1915 by Uhlenhuth and Fromme from the blood of a soldier in Belgium. CDC/NCID/Rob Weyant [email protected]
![Page 3: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/3.jpg)
Order: SpirochaetaesFamily: Spirochaetaceae
Genus: Treponema Borrelia
Family: LeptospiraceaeGenus: Leptospira
Taxonomy
![Page 4: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/4.jpg)
General Overview of Spirochaetales
Gram-negative spirochetes• Spirochete from Greek for “coiled hair”
Extremely thin and can be very long Tightly coiled helical cells with tapered
ends Motile by periplasmic flagella (a.k.a., axial
fibrils or endoflagella)
![Page 5: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/5.jpg)
General Overview of Spirochaetales
Outer sheath encloses axial fibrils wrapped around protoplasmic cylinder•Axial fibrils originate from insertion pores at both poles of cell
•May overlap at center of cell in Treponema and Borrelia, but not in Leptospira
•Differering numbers of endoflagella according to genus & species
![Page 6: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/6.jpg)
Periplasmic Flagella Diagram
![Page 7: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/7.jpg)
Tightly Coiled Spirochete
AF
OS = outer sheathAF = axial fibrils
Leptospira interrogans
![Page 8: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/8.jpg)
Cross-Section of Spirochete with
Periplasmic Flagella
NOTE: a.k.a., endoflagella, axial fibrils or axial filaments.
(Outer sheath)
Cross section of Borrelia burgdorferi
![Page 9: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/9.jpg)
Genus Species DiseaseTreponema pallidum ssp. pallidum
pallidum ssp. endemicumpallidum ssp. pertenuecarateum
Syphilis Bejel YawsPinta
Borrelia burgdorferirecurrentisMany species
Lyme disease (borreliosis)Epidemic relapsing feverEndemic relapsing fever
Leptospira interrogans Leptospirosis (Weil’s Disease)
Spirochaetales Associated Human Diseases
![Page 10: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/10.jpg)
Introduction• Spirochetal disease, finely coiled, motile,
0.1 x 6 – 20• Systemic infection manifested as
widespread vasculitis• Zoonosis• L. interogans 23 serogroups and 187
serovars• L. biflexa : non-pathogenic, saprophyte
![Page 11: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/11.jpg)
Epidemiology• Disease of the wild animals• Incidental human infection by direct or
indirect contact with the animal• 20-40s active males: farmers or soldiers in
harvest time• 9-10 peak into November
![Page 12: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/12.jpg)
Reservoires of Infection
• Rats• Dogs• Live stocks• Rodents including rabbits• Wild animals• Cats
![Page 13: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/13.jpg)
Sources of Human Infections
• Contaminated Water or soil from infected urine
• Direct animal contacts• Occupational exposure : farmers, vets,
abattoire workers• Recreational exposure : campers, swimmers,
visiting graveyards
![Page 14: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/14.jpg)
Leptospirosis in Humans• Incubation period: 2-30 days, usually 5-14 days
• Broad spectrum of manifestationsAcute undifferentiated feverDengue-like syndrome (fever, headache, myalgia)Aseptic meningitisWeill’s disease (jaundice, renal failure, bleeding)Pulmonary hemorrhage syndrome
• Case fatality rate is 5-40%>50% for pulmonary hemorrhage syndrome
• Major cause of hemorrhagic fever Albert Icksang Ko, MD
![Page 15: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/15.jpg)
Routes of Infection• Contact with water or soil contaminated animals• Direct contact with the by urine from infected source,
farmer, vets, butchers, recreational activities• Rodents carry EH fever, scrub typhus, paratyphus,
leptospirosis• Factors for high incidence : rain during harvest time,
carrier rate in rodents• Spirochetes survive longer in wet swampy conditions
![Page 16: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/16.jpg)
Pathogenesis• Entry sites : skin wounds or abrasions in hand and
feet and mucous membranes, conjunctiva, nasal, oral
• Bacteremia involving the entire body including eye, CSF
• Systemic effect and vasculitis due to endotoxin (hyaluronidase) and burrowing motility
• Hemorrhagic necrosis esp. in liver, lung, and kidneys jaundice, ARF, hemorrhages
![Page 17: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/17.jpg)
Clinical typesTypes 1986 1987Pneumonitis 33% 57.7%Rash type 17%Weil’s disease 15%Renal failure 13% 53.8%“Flue-like” 15% 13.5%Acute Hepatitis 8%Combination 86.5%
![Page 18: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/18.jpg)
Phase I (Septicemic)
• Following incubation period of 7-10 days• High spiking fever, headaches, myalgia,
arthralgias• Lasting 4 – 7 days• Proteinuria and increased creatinnine• Organism detectable but serologic diagnosis not
possible
![Page 19: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/19.jpg)
Phase II (Immune)
• Much more variable• Induction of IgM Antibodies• 1- 3 day freedom recurrence of
symptoms• Lower fever, CNS signs• Maybe cultured from urine but not from
blood or CSF
![Page 20: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/20.jpg)
Weil’s Disease• Less common but severe form• Mild phase I, initially• Followed by severe Jaundice , Azotemia,
and Hemorrhage from Lungs, GI tract, and other organs (3-6 day)
• Oliguric renal failure and Liver dysfunction dominate the clinical picture
![Page 21: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/21.jpg)
Clinical Signs of Leptospirosis • Pulmonary infiltrates, pneumonitis, hemorrhages• Conjunctival injection• Jaundice• Muscle tenderness• Abdominal tenderness• CVA tenderness• Abnormal auscultation• Erythema, petechiae, neck stiffness, adenopathy
![Page 22: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/22.jpg)
Albert Icksang Ko, MD
Clinical Signs of Leptospirosis•Conjunctival injection/hemorrhage
![Page 23: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/23.jpg)
Clinical Signs of LeptospirosisConjunctival injection/hemorrhage
![Page 24: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/24.jpg)
Laboratory Diagnosis
• Microbiologic identification : Blood or CSF first 10 days Urine second week (Fletcher’s, EMJH Medium)
• Serology: screeningMicroscopic Slide Agglutination (MST), titration & serogroup identification Microscopic Agglutination (MAT), detection of IgM (ELISA)
![Page 25: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/25.jpg)
• Presentation of early-phaseleptospirosis is non-specific.
• Misdiagnosis is common: Dengue Malaria Scrub typhus
• Misdiagnosis leads to pooroutcomes (Am J Trop Med Hyg 2001;65:657):
42% of leptospirosis cases sought care in the 1st three days of illness Of these, 61% were diagnosed as dengue Associated with increased ICU admission
(OR, 2.7 [0.8-9.5]) and mortality (OR, 5.1 [0.8-55.0]).
A Tarde, Salvador, June 1996
Barriers to Timely Identification and Treatment
Albert Icksang Ko, MD
![Page 26: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/26.jpg)
Need for Rapid Diagnostics for Leptospirosis
•Current serologic tests have<30-50% sensitivity during the1st week of illness
•Lig proteins are immunodominant antigens (J Clin Microbiol 2007;45:1528) Sensitivity and specificity >90-95%
•Improved sensitivity (80%) during the 1st week of illness.
•Fiocruz-Cornell is developing a Lig-based lateral flow assay Point-of-care diagnosis Clinical evaluation in 2009Albert Icksang Ko, MD
![Page 27: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/27.jpg)
Chest X-rays
• 33 – 64 % of patientssjows abnormality• Bilateral nodules, rosette densities• Diffuse ill-defined infiltrates• Massive confluent consolidation• Bilateral, Non-lobar, peripheral predominance• Rare pleural reaction• Complete resolution within 5 to 10 days
![Page 28: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/28.jpg)
Differential Diagnosis
• EH fever• Rickettsial disease : Scrub typhus, murine
typhus• Acute viral hepatitis• Sepsis• Influenza• Aseptic Meningitis
![Page 29: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/29.jpg)
Treatment
• Early anti-microbial therapy is importantshorten the course and prevent carrier state
• Choice : Penicillin G, Ampicillin• May cause “ Jarish-Herxheimer type
reaction” • Mild cases oral Doxycycline or Amoxicillin
![Page 30: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/30.jpg)
Prevention
• Vaccination of domestic animals• Rodent control• Protective gloves and boots• Avoid swimming in contaminated waters• Vaccination in endemic region
![Page 31: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/31.jpg)
• Reduce reservoir densityPesticidesDeny access to human living environmentDeny access to food and waterRemove food sources and ecological habitats
• Limitations:Pesticides are costly.Rodent control can not be accomplished by
chemical interventions alone (recrudescence, pesticide resistance).
Control of Rodent Sources of Transmission
Albert Icksang Ko, MD
![Page 32: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/32.jpg)
Prevent Exposures to Transmission Sources• Disinfecting areas of contaminated
environment (hypochlorite)
• Protective clothing (boots, gloves)
• Cleaning wounds after exposure
• Prevention of contact with ill or dead animals
• Health education on risk exposures
• Remove transmission sources
![Page 33: Leptospirosis UPH 2](https://reader034.vdocuments.site/reader034/viewer/2022052514/577cce051a28ab9e788d18db/html5/thumbnails/33.jpg)
What good does it do to treat people's illnesses ...
then send them back to the conditions that made them sick?
Michael Marmot, Commission of Social Determinants of Health, WHO